Integral Ad Science Holding Corp. $IAS Position Raised by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. increased its stake in Integral Ad Science Holding Corp. by 0.5% in the first quarter, owning approximately 9.09 million shares valued at $73.27 million as of its latest SEC filing.
• Institutional investors now own 95.78% of Integral Ad Science, with various hedge funds acquiring new stakes totaling significant investments in recent quarters.
• Integral Ad Science reported a net margin of 9.79% and earnings per share of $0.07 for the last quarter, exceeding analyst expectations and setting guidance for future earnings.

Vanguard Group Inc. boosted its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 0.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 9,090,229 shares of the company's stock after buying an additional 41,683 shares during the period. Vanguard Group Inc. owned approximately 5.55% of Integral Ad Science worth $73,267,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of IAS. Alyeska Investment Group L.P. purchased a new position in Integral Ad Science in the fourth quarter valued at approximately $41,543,000. Dimensional Fund Advisors LP raised its holdings in Integral Ad Science by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after buying an additional 580,323 shares during the period. Clearline Capital LP purchased a new position in Integral Ad Science in the fourth quarter valued at approximately $3,949,000. Invenomic Capital Management LP raised its holdings in Integral Ad Science by 52.9% in the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock valued at $9,344,000 after buying an additional 309,752 shares during the period. Finally, Ararat Capital Management LP raised its stake in shares of Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock valued at $23,823,000 after purchasing an additional 269,346 shares during the period. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Trading Up 1.5%

Integral Ad Science stock traded up $0.14 during mid-day trading on Thursday, reaching $9.18. The company's stock had a trading volume of 395,643 shares, compared to its average volume of 1,009,499. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 1.28 and a beta of 1.57. The business has a 50 day moving average price of $8.42 and a 200-day moving average price of $8.40. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. The firm had revenue of $149.20 million during the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

IAS has been the topic of a number of analyst reports. Raymond James Financial dropped their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Barclays lifted their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research note on Friday, August 8th. Stifel Nicolaus lifted their price objective on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Finally, Wall Street Zen upgraded shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of Integral Ad Science stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total value of $123,852.24. Following the completion of the transaction, the chief executive officer owned 379,316 shares of the company's stock, valued at $3,152,115.96. The trade was a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders have sold a total of 35,073 shares of company stock valued at $289,641 over the last three months. Insiders own 2.00% of the company's stock.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.